Transfusion Practices for Children in Germany, Austria, and Switzerland - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Pediatric Transfusion Practices in Germany, Austria, and Switzerland

  • By

  • Eva Wittenmeier

  • Katharina Roehrs

  • Eva Herrmann

  • Johanna H. Steinberg

  • Christiane E. Beck

  • Andrea U. Steinbicker

  • TRAPA investigator study group

  • Hannah-Sophie Arbeiter

  • Gregor Badelt

  • Karin Becke-Jakob

  • Nicole Bewersdorf

  • Carolin Böhne

  • Patrick Booms

  • Jens Brands

  • Thorsten Brenner

  • Luisa Cremers

  • Nora Doberschütz

  • Christoph Eich

  • Dania Fischer

  • Thomas Fischer

  • Peter J Follmann

  • Ulrich Gosch

  • Ulrike Herberg

  • Egbert Hüttemann

  • Martin Keller

  • Isabel Kiesewetter

  • Dieter Klarmann

  • Maren Kleine-Brueggeney

  • Svea Kleiner

  • Markus Knuf

  • Oliver Kunitz

  • Karsten Laabs

  • Matthias Lange

  • Thomas Lehrnbecher

  • Anna Katharina Masseli

  • Chris Mohrmann

  • Marcus Nemeth

  • Kornelius Padberg

  • Tobias Piegeler

  • Florian Piekarski

  • Greta A. Polley

  • Vanessa Rigterink

  • Ulrich Rochwalsky

  • Udo Rolle

  • Armin Sablewski

  • Ehrenfried Schindler

  • Miriam Schneider

  • Antje Seidel

  • Benjamin Siebald

  • Barbara Sinner

  • Ezgi Sönmez

  • Alexander Sterlin

  • Andrea Uebler

  • Reiner M. Waeschle

  • Carola Wempe

  • Astrid Wintering

  • Kai Zacharowski

  • Bernhard Ziegler

  • November 20, 2026

Share

Objective:

To prospectively describe transfusion practices, triggers, products, settings, and clinical circumstances among children of all ages in Germany, Austria, and Switzerland.

Approach:
  • Design: Prospective multicenter observational cohort study (TRAPA) of pediatric transfusion events.
  • Data: After excluding 51 incomplete records, the analysis included 1,330 events involving 1,834 transfused products in children aged 0 days to 17 years.
Key Findings:
  • Nonoperative, noninterventional care accounted for 56.5% of events; postoperative care accounted for 23.9%, and intraoperative care for 16.9%.
  • RBCs were the most frequent product overall. Single-product transfusions made up more than three-quarters of events; isolated RBC and platelet transfusions accounted for 45.7% and 22.6%, respectively.
  • Half of transfused children were classified as clinically unstable. Bleeding was documented in 14.4% of events and impaired coagulation in 22.2%.
  • RBCs were the predominant product in each age group except ages 12 to 17, in which platelets were most frequent. Every product type was used across all age groups.
Interpretation:

The study provides prospective multicenter data on pediatric transfusions and associated clinical circumstances across a broad range of ages and care settings. The authors note that evidence and guidelines for this population remain limited.

Limitations:
  • Anonymous reporting prevented comparisons between centers and longitudinal tracking of individual patients.
  • Not all hospitals participated; optional survey items and physician selection may have led to missing data and inclusion bias, limiting generalizability.

Original Source(s)

Related Content